Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer. [electronic resource] by
- Hecht, J Randolph
- Mitchell, Edith
- Chidiac, Tarek
- Scroggin, Carroll
- Hagenstad, Christopher
- Spigel, David
- Marshall, John
- Cohn, Allen
- McCollum, David
- Stella, Philip
- Deeter, Robert
- Shahin, Seta
- Amado, Rafael G
Producer: 20090226
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27
Availability: No items available.
|
|
7.
|
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib. [electronic resource] by
- Ulaner, Gary A
- Saura, Cristina
- Piha-Paul, Sarina A
- Mayer, Ingrid
- Quinn, David
- Jhaveri, Komal
- Stone, Ben
- Shahin, Seta
- Mann, Grace
- Dujka, Melanie
- Bryce, Richard
- Meric-Bernstam, Funda
- Solit, David B
- Hyman, David M
Producer: 20201026
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|